[Mood disorders]

Rev Prat. 2008 Oct 31;58(16):1809-14.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / therapeutic use
  • Antidepressive Agents, Tricyclic / administration & dosage
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / drug therapy
  • Anxiety Disorders / therapy
  • Bipolar Disorder / diagnosis
  • Cyclohexanols / administration & dosage
  • Cyclohexanols / therapeutic use
  • Depressive Disorder / diagnosis
  • Depressive Disorder / drug therapy
  • Depressive Disorder / etiology
  • Depressive Disorder / psychology
  • Depressive Disorder / therapy
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Electroconvulsive Therapy
  • Female
  • Hospitalization
  • Humans
  • Male
  • Mood Disorders* / diagnosis
  • Mood Disorders* / drug therapy
  • Mood Disorders* / psychology
  • Mood Disorders* / therapy
  • Personality Disorders / diagnosis
  • Pregnancy
  • Prognosis
  • Psychotherapy
  • Psychotropic Drugs / administration & dosage
  • Psychotropic Drugs / therapeutic use
  • Recurrence
  • Schizophrenia / diagnosis
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Suicide
  • Time Factors
  • Venlafaxine Hydrochloride
  • Young Adult

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic
  • Cyclohexanols
  • Psychotropic Drugs
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride